A digoxigenin-labeled probe was produced from the Pasteur virus strain for the detection of the rabies virus N gene. The probe hybridization was performed from amplified N gene obtained by reverse transcription polymerase chain reaction and the results by RT-PCR and hybridization showed 100% agreement. The hybridization, when carried out in products amplified by RT-PCR, increases the sensitivity of this technique even more and confers specificity to the diagnosis. The technique described in this work will be useful in rabies diagnosis laboratories, once the cost is compatible with traditional rabies diagnostic techniques. Key-words: Rabies. N Gene. Reverse transcription polymerase chain reaction. Probe. Hybridization.
Rabies is a fatal cosmopolitan zoonosis of viral origin, which affects the central nervous system of mammals and is the 11 th cause of human death among infectious diseases 19 . The rabies virus belongs to the Lyssavirus genus of the Rhabdoviridae family 15 and, up to the present, even though there are 7 existing genotypes worldwide, the only genotype isolated in Brazil is genotype 1 10 . Dogs and vampire bats are the main reservoirs of the virus in Brazil, but other nonhematophagous bats also act as virus reservoirs 2 .
Some studies with nucleoprotein gene (N) in Brazil point to the existence of two main variants of the rabies virus (RABV): one found in the urban cycle, domestic animals and humans; and the other in the sylvatic cycle (hematophagous bats and cattle); and these two cycles overlap in many areas 10 11 . However, in 2001 an epidemiological cycle of rabies in Northeastern Brazil was described 6 , in which the marmoset (Callithrix jacchus) was responsible for the maintenance of the cycle.
Rabies diagnosis laboratories remain of utmost importance in countries where this disease still affects humans and domestic animals 7 . Laboratory techniques for diagnosis identify RABV in the central nervous system (CNS) with polyclonal antibodies or anti-nucleoprotein antibodies used in a direct fluorescent antibody test (FAT) and can be isolated by brain inoculation in mice (MIT), as recommended by the World Health Organization 19 (WHO). Despite the fact that FAT is the gold-standard technique, this test can fail in decomposed samples or those with a small viral concentration 8 .
The genetic diagnosis of RABV is usually carried out by direct demonstration of the N gene by RT-PCR or indirectly, by performing hybridization after amplification by reverse transcription polymerase chain reaction (RT-PCR) 13 . RT-PCR in an ante mortem diagnosis, allows for early detection of the infection and post-exposure prophylaxis for people exposed to the virus sources 5 .
In general, DNA sequencing is used to carry out the genetic typing of RABV, frequently used in molecular epidemiology 1 3 . However, the utilization of a monoclonal-antibodies panel is of fundamental importance, since immunological detection is reliable and indicative of nonsilent genetic changes 4 12 .
RT-PCR amplification does not present sufficient specificity in highly degraded samples because unspecific band migrations can occur 12 . However, amplified products hybridized with probes, following Southern blot, characterizes specific and unspecific bands 13 . The simultaneous use of RT-PCR and probes avoid the risk of false-positive results in diagnoses by increasing sensitivity and specificity 18 . The present study was aimed at the production of a digoxigenin-labeled probe for the detection of RABV N gene in a safe and economic manner and to add one more home-made technique to the set of ready-to-use techniques for rabies diagnosis.
MATERIAL AND METHODS

Samples.
Fourteen clinical samples of Brain Tissue from the Pasteur Institute, SP, Brazil and the Veterinary Medicine School of São Paulo University, Brazil, all positive by FAT and MIT, were included in this study. The Pasteur virus strain (PV) was used, as standard positive control, while a rabies negative CNS sample, as tested by FAT and MIT, as well as ultra-pure water, were included as a negative control. Each step, RNA extraction, RT-PCR, electrophoresis and probe assays, was carried out in separate rooms with exclusive materials and equipments.
Primers. The primers for the rabies virus N gene were designed from the nucleotide sequence of the PV strain, obtained from the GenBank (accession number M13215). Primers for the N gene were named N1 5´ ATG GAT GCC GAC AAG ATT 3( sense) and N2 5´ TTA TGA GTC ACT CGA ATA 3´ (anti-sense) (positions 71-89 and 1403-1421 of the PV strain).
RNA Extraction, Reverse Transcription and PCR. Total RNA from the clinical samples and the PV standard sample was extracted with Trizol (Invitrogen TM ) according to the manufacturer's instructions. Extracted RNA was reverse transcribed in a mix containing 50pMoles of primers N1/N2, 50mM Tris-HCl, 75mM KCl, 3mM MgCl 2 , 10mM DTT, 200U Reverse Transcriptase (Superscript  TM II -Invitrogen   TM   ) , 20U Rnase inhibitor, 1.5mM dNTP in a final volume of 40µL. The mix was incubated at 42°C for 1 hour. The cDNA synthesized was amplified with the same primers by PCR in a mix containing 10µL of cDNA, 20mM Tris HCl, 50mM KCl, 1.5mM MgCl 2 , 50pMoles of each primer (N1/N2), 2.5U Taq DNA Polymerase (Invitrogen TM ) and 200mM dNTP in a final volume of 100µL. Amplification conditions consisted of 5 min at 94°C, followed by 35 cycles of PCR (94°C for 45 sec, 55°C for 45 sec, 72°C for 1 min and 30 sec) and 7 min at 72°C.
Construction of the probe and labeling with digoxygenin.
The "DIG DNA Labeling Kit" system was used (Boehringer Mannheim) for N probe production. The N gene was obtained by RT-PCR amplification of the PV sample as described above. Next, the amplified band was excised from the agarose gel, dialyzed in TBE 0.5% and electroeluted under 100V for 1 hour and purified with phenol/ chloroform, as described by Sambrook et al 8 , then re-suspended in 20µL TE. Two µL of this purified product were diluted in 15µL of ultra-pure water and boiled at 100°C for 10 minutes and then cooled in dry-ice with ethanol. After thawing, the product described above was added to 2µL of hexanucleotides (dUTP), 2µL of dNTP-DIG, 1µL of Klenow enzyme, in order to generate a pool of random fragments complementary to the N gene. After 12 hours at 37°C, the reaction was diluted in 150µL of TE, added to a spin column with positive charge and centrifuged at 2000g. Finally, the product (DNA labeled with digoxigenin) was diluted within 30µL of ultra-pure water.
Southern-blot hibridization and detection by the Immunechemiluminescence. After electrophoresis of the RT-PCR products derived from the clinical samples, denaturation of the products was realized by keeping the gel under denaturant buffer (0.5N NaOH; 1.5M NaCI;) for 60 minutes, neutralizing it in neutralizing buffer (0.5M Tris-HCl; 1.5 M NaCI; pH 7.5) for 30 minutes and transferring it for 60 minutes to a nylon membrane using a Vaccum Blotter (Bio-RAD, Melville, NY, USA), with 127mmHg for 90 min in 20 X SSC (3M NaCI; 0.3M citrate of sodium; pH 7.0) buffer. After two immobilization cycles of the product under UV radiation in Ultraviolet Cross Linker (Amersham International plc, Littie Chelfont, Bucks, England, UK), the membrane was prehybridized in buffer [5 x SSC; 0.02% (w/v) SDS; 1% (w/v) of blocked reagent (Boehringer Mannheim)] for 1 hour, at 60°C, and hybridized utilizing the previous buffer added to the digoxigenin-marked probe to a final concentration of 10 pmol/mL in a Hybridization Oven/Shaker System (Amersham, International), in roller tubes for 6 hours at 60°C, as a factor of stringency. Next, the membrane was kept in blocking solution [(100mMTris-HCI; 150m M NaCI; 2% (w/v) of reagent of blocked; pH 7.0)] for 1 hour and replaced by the washing buffer (100m M Tris-HCI; 150m M NaCI) for 2 minutes. Then, the reaction was added to blocking solution with anti-digoxygenin antibody conjugated with alkalinephosphatase (antidigoxigenin-AP Fab fragments-Boehringer Mannhelm), at 250mU/mL, for 30 minutes, followed by two 15 minutes washes in washing buffer and, finally, washed in equilibrium buffer (100mM Tris-HCI; 100 mM NaCI; 50mM MgCl 2 ; pH 9,5) for 5 minutes. Detection was carried out by adding 1mL of LUMI-PHOS 530 (Boehringer Mannhelm) to the membrane inserted between acetate sheets, incubated at 37°C, for 30 minutes and exposed to a X-OMat AR film (Eastman Kodak CO., Rochester) for a variable period of 1 to 4 minutes and developed in a dark room.
RESULTS
All samples diagnosed as positive for rabies virus by FAT and MIT were confirmed as positive by RT-PCR and with the N probe. Also, the samples negative by FAT and MIT were also negative by RT-PCR and with the N probe ( Table 1 and Figure 1) . 
DISCUSSION
The production of the probe presented in this work aimed to propose an alternative approach for the genetic diagnosis of RABV by detection of the N gene. RABV must be detected in a fast and safe manner and its diagnosis needs to be constantly improved. The direct fluorescent antibody test (FAT), established by the WHO, is quick, simple, sensitive and has a reasonable cost. However, in some situations, this technique is not efficient, as in decomposed or formalin-fixed samples 17 . The WHO recommends the use of a complementary test, such as brain inoculation in mice (MIT), which can take up to 25 days to produce a conclusive result, has a high financial cost and is not reliable in decomposed samples 19 .
In situations where the isolation of the virus is impossible, as mentioned above, the use of RT-PCR is of primary importance 9 . The RT-PCR technique offers sensitivity and a reduced time for result acquisition at a cost that is compatible with other methodologies, but offers risks regarding falsepositive results due to the potential cross-contamination of samples 16 . Hybridization, when carried out in products amplified by RT-PCR, increases the sensitivity of this technique even more and confers specificity to the diagnosis 13 .
The ability to detect rabies virus in clinical samples can be increased with the use of a second amplification step, using the technique of Nested PCR, but this procedure increases the risk of false-positive results due to DNA contamination. One advantageous aspect of hybridization is a lower probability of laboratory contamination with DNA, and its sensitivity is comparable to Nested-PCR 8 .
Despite the fact that molecular techniques are routinely used, they have been restricted to special diagnosis situations and to laboratories able to carry out such techniques. In these cases, the probe described here targeted to the N gene, might be useful to increase the accuracy of the results obtained with RT-PCR. Yet, home-made probes are much more economic when compared to commercial probes, which makes them a viable alternative for laboratories intending to carry out rabies diagnosis and rabies virus diversity based on nucleic acids. Finally, nonradioactive probes not only have a longer half life but also are safer, since they avoid the manipulation of radioactive isotopes.
Probe sequencing was not performed in the present research due to the presence of various molecules of digoxigenin in the N probe pool, which was randomly produced, according to the DIG DNA Labeling KIT methodology, and could inhibit sequencing reactions. Furthermore, as described in Material and Methods, the probe was produced as a pool of random fragments with multiple sizes and sequences primed with hexanucleotides (dUTP), a process that imposes technical difficulties in the determination of these sequences.
Nonetheless, as the probe was generated with the whole N gene amplified by PCR as a template, it could be argued that only N gene specific segments were obtained.
Besides, the random characteristics of the pool of segments in the N probe enhance the sensitivity of RABV detection, since variants of the virus with small nucleotide differences in an N gene can be detected.
The 14 field strains of rabies virus tested by the digoxigeninlabeled probe described in this article, demonstrate that such a probe may be used on a larger number of field samples after RT-PCR, in order to increase the specificity of the results in a faster, easier and more economic manner when compared to DNA sequencing, while also avoiding chromatogram misinterpretations due to sequencing errors.
The N gene is the most conserved region on the RABV genome and, for this reason, is the target for diagnosis 1 . In this research, the PV strain was used for production of the N probe, since this is a widely used vaccine strain and, theoretically, possesses antigenic and genetic characteristics similar to a large number of populations of circulating rabies virus. The results presented herein show that the probe produced allowed for the detection of the N gene in rabies-positive samples from the two most important populations of rabies reservoirs: dogs and vampire bats.
In conclusion, the N probe produced in the research described in this article from the full length of the amplified N gene of RABV has a high capacity to detect RABV in clinical samples. The production of probes for the detection of the N gene reinforces the importance of the development of molecular methods for the diagnosis of RABV.
